MARKET

MRK

MRK

Merck & Co
NYSE
120.84
+0.55
+0.46%
Pre Market: 120.84 0 0.00% 07:50 04/02 EDT
OPEN
120.88
PREV CLOSE
120.29
HIGH
122.19
LOW
120.27
VOLUME
1.87K
TURNOVER
--
52 WEEK HIGH
124.22
52 WEEK LOW
70.74
MARKET CAP
298.76B
P/E (TTM)
16.60
1D
5D
1M
3M
1Y
5Y
1D
Merck initiates Phase 2b/3 trial evaluating MK-8748
TipRanks · 2h ago
Merck’s Keytruda in combination approved in EU for ovarian carcinoma
TipRanks · 2h ago
Merck Says EU Approves KEYTRUDA, In Combination With Paclitaxel, With Or Without Bevacizumab, For Treatment Of Platinum-Resistant Epithelial Ovarian, Fallopian Tube Or Primary Peritoneal Carcinoma In Adults
Benzinga · 3h ago
Trump administration readying new pharmaceutical tariffs, FT reports
TipRanks · 3h ago
Merck Announces Initiation of Pivotal Phase 2b/3 Trial Evaluating MK-8748 (Tiespectus), an Investigational Bispecific Tie2 Agonist/VEGF Inhibitor, for the Treatment of Neovascular Age-Related Macular Degeneration
Barchart · 7h ago
No deal yet? Trump readies 100% tariffs on select drugmakers - report
Seeking Alpha · 8h ago
Lilly CEO says company opposes codification of Trump drug pricing deals
Seeking Alpha · 16h ago
Merck Taps Infinimmune AI Antibodies To Support Long Term Growth Narrative
Simply Wall St · 17h ago
More
About MRK
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.

Webull offers Merck & Co Inc stock information, including NYSE: MRK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRK stock methods without spending real money on the virtual paper trading platform.